TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 13

1.1 GLOBAL INDUSTRIAL ENZYMES MARKET, BY SOURCE 15

1.2 GLOBAL INDUSTRIAL ENZYMES MARKET, BY TYPE 16

1.3 GLOBAL INDUSTRIAL ENZYMES MARKET, BY APPLICATION 17

1.4 GLOBAL INDUSTRIAL ENZYMES MARKET, BY REGION 18

2 MARKET INTRODUCTION 19

2.1 DEFINITION 19

2.2 SCOPE OF THE STUDY 19

2.3 MARKET STRUCTURE 20

3 RESEARCH METHODOLOGY 21

3.1 RESEARCH PROCESS 21

3.2 PRIMARY RESEARCH 22

3.3 SECONDARY RESEARCH 23

3.4 MARKET MATERIAL ESTIMATION 24

3.5 TOP DOWN & BOTTOM-UP APPROACH 24

3.6 FORECAST MODEL 25

3.7 LIST OF ASSUMPTIONS 26

4 MARKET DYNAMICS 27

4.1 INTRODUCTION 27

4.2 DRIVERS 27

4.2.1 GROWING DEMAND FROM FOOD AND BEVERAGE APPLICATIONS 27

4.2.2 MAKING INDUSTRIES MORE ENVIRONMENTALLY FRIENDLY 28

4.2.3 DRIVERS IMPACT ANALYSIS 29

4.3 RESTRAINT 29

4.3.1 LACK OF STANDARD REGULATORY SCENARIO 29

4.3.2 HIGH PRICES OF RAW MATERIALS AND PRODUCTS 30

4.3.3 RESTRAINT IMPACT ANALYSIS 30

4.4 OPPORTUNITIES 31

4.4.1 DEMAND FOR NATURAL SUBSTITUTES OF SYNTHETIC CHEMICALS 31

4.5 ENZYME REGULATION AND QUALITY ASSURANCE 31

4.5.1 DETERGENT ENZYMES 31

4.5.2 FOOD ENZYMES 31

4.6 IMPACT OF COVID-19 ON THE GLOBAL ECONOMY 32

4.7 IMPACT OF COVID-19 ON THE GLOBAL INDUSTRIAL ENZYMES MARKET 34

5 MARKET FACTOR ANALYSIS 36

5.1 SUPPLY/VALUE CHAIN ANALYSIS 36

5.1.1 RAW MATERIALS 37

5.1.2 INDUSTRIAL ENZYMES MARKET MANUFACTURING 37

5.1.3 DISTRIBUTION & SALES 37

5.1.4 END-USER 38

5.2 PORTER’S FIVE FORCES MODEL 38

5.3 THREAT OF NEW ENTRANTS 39

5.3.1 BARGAINING POWER OF SUPPLIERS 39

5.4 BARGAINING POWER OF BUYERS 39

5.5 THREAT OF SUBSTITUTES 40

5.6 INTENSITY OF RIVALRY 40

6 GLOBAL INDUSTRIAL ENZYMES MARKET, BY SOURCE 41

6.1 OVERVIEW 41

6.2 PLANT 41

6.3 ANIMAL 43

6.4 MICROORGANISMS 44

7 GLOBAL INDUSTRIAL ENZYMES MARKET, BY TYPE 45

7.1 OVERVIEW 45

7.2 CARBOHYDRASES 46

7.3 PROTEASES 47

7.4 LIPASES 48

7.5 OTHERS 49

8 GLOBAL INDUSTRIAL ENZYMES MARKET, BY APPLICATION 50

8.1 OVERVIEW 50

8.2 FOOD & BEVERAGES 51

8.3 ANIMAL FEED 52

8.4 DETERGENT & CLEANERS 53

8.5 PERSONAL CARE 54

8.6 PHARMACEUTICALS AND NUTRACEUTICALS 54

8.7 OTHERS 55

9 GLOBAL INDUSTRIAL ENZYMES MARKET, BY REGION 56

9.1 OVERVIEW 56

9.2 NORTH AMERICA 58

9.2.1 US 60

9.2.2 CANADA 62

9.2.3 MEXICO 63

9.3 EUROPE 64

9.3.1 GERMANY 67

9.3.2 UK 68

9.3.3 FRANCE 69

9.3.4 SPAIN 70

9.3.5 ITALY 71

9.3.6 REST OF EUROPE 72

9.4 ASIA PACIFIC 73

9.4.1 CHINA 75

9.4.2 INDIA 77

9.4.3 JAPAN 78

9.4.4 AUSTRALIA & NEW ZEALAND 79

9.4.5 REST OF ASIA-PACIFIC 80

9.5 REST OF THE WORLD 81

9.5.1 MIDDLE EAST 84

9.5.2 AFRICA 85

9.5.3 SOUTH AMERICA 86

10 COMPETITIVE LANDSCAPE 87

10.1 COMPETITIVE OVERVIEW 87

10.2 MAJOR GROWTH STRATEGY IN THE GLOBAL INDUSTRIAL ENZYMES MARKET 87

10.3 COMPETITIVE BENCHMARKING 89

11 COMPANY PROFILES 90

11.1 CHR. HANSEN HOLDING A/S 90

11.1.1 COMPANY OVERVIEW 90

11.1.2 FINANCIAL OVERVIEW 91

11.1.3 PRODUCTS OFFERED 91

11.1.4 KEY DEVELOPMENTS 92

11.1.5 SWOT ANALYSIS 93

11.1.6 KEY STRATEGIES 93

11.2 BASF SE 94

11.2.1 COMPANY OVERVIEW 94

11.2.2 FINANCIAL OVERVIEW 95

11.2.3 PRODUCTS OFFERED 95

11.2.4 KEY DEVELOPMENTS 96

11.2.5 SWOT ANALYSIS 97

11.2.6 KEY STRATEGIES 97

11.3 DUPONT DE NEMOURS, INC 98

11.3.1 COMPANY OVERVIEW 98

11.3.2 FINANCIAL OVERVIEW 99

11.3.3 PRODUCTS OFFERED 99

11.3.4 KEY DEVELOPMENTS 100

11.3.5 SWOT ANALYSIS 102

11.3.6 KEY STRATEGIES 102

11.4 KONINKLIJKE DSM N.V. 103

11.4.1 COMPANY OVERVIEW 103

11.4.2 FINANCIAL OVERVIEW 104

11.4.3 PRODUCTS OFFERED 104

11.4.4 KEY DEVELOPMENTS 105

11.4.5 SWOT ANALYSIS 106

11.4.6 KEY STRATEGIES 106

11.5 NOVOZYMES A/S 107

11.5.1 COMPANY OVERVIEW 107

11.5.2 FINANCIAL OVERVIEW 108

11.5.3 PRODUCTS OFFERED 108

11.5.4 KEY DEVELOPMENTS 109

11.5.5 SWOT ANALYSIS 110

11.5.6 KEY STRATEGIES 110

11.6 ADVANCED ENZYME TECHNOLOGIES LTD 111

11.6.1 COMPANY OVERVIEW 111

11.6.2 FINANCIAL OVERVIEW 112

11.6.3 PRODUCTS OFFERED 112

11.6.4 KEY DEVELOPMENTS 113

11.6.5 KEY STRATEGIES 113

11.7 ADISSEO 114

11.7.1 COMPANY OVERVIEW 114

11.7.2 FINANCIAL OVERVIEW 115

11.7.3 PRODUCTS OFFERED 116

11.7.4 KEY DEVELOPMENTS 116

11.7.5 KEY STRATEGIES 116

11.8 DYADIC INTERNATIONAL INC. 117

11.8.1 COMPANY OVERVIEW 117

11.8.2 FINANCIAL OVERVIEW 117

11.8.3 PRODUCTS OFFERED 118

11.8.4 KEY DEVELOPMENTS 118

11.9 KERRY GROUP PLC 119

11.9.1 COMPANY OVERVIEW 119

11.9.2 FINANCIAL OVERVIEW 120

11.9.3 PRODUCTS OFFERED 120

11.9.4 KEY DEVELOPMENTS 121

11.9.5 KEY STRATEGIES 122

11.10 AMANO ENZYME INC 123

11.10.1 COMPANY OVERVIEW 123

11.10.2 FINANCIAL OVERVIEW 123

11.10.3 PRODUCTS OFFERED 123

11.10.4 KEY DEVELOPMENTS 123